Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6)

H Bischoff, MC Garassino, J Mazieres, M Reck, C Chouaid, L Cove-Smith, T Mansy, MR Migliorino, A Delmonte, JG Sanchez, LEC Velarde, R Bernabe, L Paz-Ares, ID Perez, N Trunova, K Foroutanpour, C Faivre-Finn, N Reinmuth

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)160-161
Number of pages2
JournalOncology Research and Treatment
Issue numberSUPPL 3
Publication statusPublished - Nov 2022

Cite this